International Medical Case Reports Journal

The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study

This case study (n=1) describes an immunocompetent male with neuropsychiatric Lyme disease who did not respond to conventional treatments. However, his symptoms improved when he started using psilocybin in sub-hallucinogenic doses. Psilocybin is both serotonergic and anti-inflammatory, which may benefit patients with mental illness secondary to autoimmune inflammation.

Published

March 1, 2023

Journal

International Medical Case Reports Journal

Authors

Kinderlehrer, D. A.